Evidence map›Paper›PMID 28592828›Full record

ArticleScientific reports2017

A highly conserved sequence of the viral TAP inhibitor ICP47 is required for freezing of the peptide transport cycle.

Tony Matschulla, Richard Berry, Carolin Gerke, Marius Döring, Julia Busch, Jennifer Paijo, Ulrich Kalinke, Frank Momburg, Hartmut Hengel, Anne Halenius

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Diverse cytomegalovirus US11 antagonism and MHC-A evasion strategies reveal a tit-for-tat coevolutionary arms race in hominids.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Tony MatschullaInstitute of Virology, Medical Center - University of Freiburg, Freiburg, Germany.
Richard BerryInfection and Immunity Program, Dept. of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Carolin GerkeInstitute of Virology, Medical Center - University of Freiburg, Freiburg, Germany.
Marius DöringInstitute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Feodor-Lynen-Str. 7, 30625, Hannover, Germany.
Julia BuschInstitute of Virology, University of Duesseldorf, Universitaetsstr. 1, 40225, Duesseldorf, Germany.
Jennifer PaijoInstitute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Feodor-Lynen-Str. 7, 30625, Hannover, Germany.
Ulrich KalinkeInstitute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Feodor-Lynen-Str. 7, 30625, Hannover, Germany.
Frank MomburgClinical Cooperation Unit, Applied Tumor Immunity, Antigen Presentation and T/NK Cell Activation Group, German Cancer Research Center, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Hartmut HengelInstitute of Virology, Medical Center - University of Freiburg, Freiburg, Germany.
Anne HaleniusInstitute of Virology, Medical Center - University of Freiburg, Freiburg, Germany. anne.halenius@uniklinik-freiburg.de.
University of Freiburg · DEMedizinische Hochschule Hannover · DEAustralian Regenerative Medicine Institute · AUCenter for Experimental and Clinical Infection Research · DEHeidelberg University · DEHeinrich Heine University Düsseldorf · DEUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transporter associated with antigen processing (TAP) translocates antigenic peptides into the endoplasmic reticulum (ER) lumen for loading onto MHC class I molecules. This is a key step in the control of viral infections through CD8+ T-cells. The herpes simplex virus type-1 encodes an 88 amino acid long species-specific TAP inhibitor, ICP47, that functions as a high affinity competitor for the peptide binding site on TAP. It has previously been suggested that the inhibitory function of ICP47 resides within the N-terminal region (residues 1-35). Here we show that mutation of the highly conserved

Indexed as

Amino Acid SequenceConserved SequenceAnimalsBinding SitesCell LineHumansImmediate-Early ProteinsPeptidesProtein BindingProtein ConformationProtein TransportRatsStructure-Activity RelationshipViral ProteinsICP47 protein, Herpes simplex virusImmediate-Early ProteinsPeptidesViral Proteins

Identifiers

PMID28592828
PMCPMC5462769
OpenAlexW2620874968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.